Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change UBS analysts reiterated a Buy rating on MapLight Therapeutics, Inc. (NASDAQ:MPLT) on July 21, 2026. Market Context MapLight Therapeutics, Inc.
Read moreRating Change Canaccord Genuity analysts initiated coverage on Brazil Potash Corp. (NYSE:GRO) with a Speculative Buy rating on July 21, 2026. Market Context Brazil Potash Corp.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Centerspace (NYSE:CSR) on July 21, 2026. Market Context Centerspace operates in the Real Estate sector. The…
Read moreRating Change UBS analysts initiated coverage on ATRenew Inc. (NYSE:RERE) with a Buy rating on July 21, 2026. Market Context ATRenew Inc.
Read moreRating Change Scotiabank analysts reiterated a Sector Perform rating on Douglas Emmett, Inc. (NYSE:DEI) on July 21, 2026. Market Context Douglas Emmett, Inc.
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Douglas Emmett, Inc. (NYSE:DEI) on July 21, 2026. Market Context Douglas Emmett, Inc.
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Genesis Energy, L.P. (NYSE:GEL) on July 21, 2026. Market Context Genesis Energy, L.P.
Read moreRating Change Jones Trading analysts reiterated a Buy rating on Dynex Capital, Inc. (NYSE:DX) on July 21, 2026. Market Context Dynex Capital, Inc.
Read moreRating Change Benchmark analysts initiated coverage on Stewart Information Services Corporation (NYSE:STC) with a Buy rating on July 21, 2026. Market Context Stewart Information…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Delek US Holdings, Inc. (NYSE:DK) on July 21, 2026. Market Context Delek US Holdings, Inc.
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Tarsus Pharmaceuticals, Inc. Common Stock (NASDAQ:TARS) on July 21, 2026. Market Context Tarsus Pharmaceuticals, Inc.
Read moreRating Change Citigroup analysts initiated coverage on Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) with a Buy rating on July 21, 2026. Market Context Ligand Pharmaceuticals…
Read moreRating Change Benchmark analysts reiterated a Buy rating on Red Rock Resorts, Inc. (NASDAQ:RRR) on July 21, 2026. Market Context Red Rock Resorts, Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on DigitalOcean Holdings, Inc. (NYSE:DOCN) on July 21, 2026. Market Context DigitalOcean Holdings, Inc.
Read moreRating Change Baird analysts reiterated a Neutral rating on Zions Bancorporation, National Association (NASDAQ:ZION) on July 21, 2026. Market Context Zions Bancorporation,…
Read moreRating Change TD Cowen analysts reiterated a Hold rating on Zions Bancorporation, National Association (NASDAQ:ZION) on July 21, 2026. Market Context Zions Bancorporation,…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Zions Bancorporation, National Association (NASDAQ:ZION) on July 21, 2026. Market Context Zions…
Read moreRating Change DA Davidson analysts reiterated a Buy rating on Zions Bancorporation, National Association (NASDAQ:ZION) on July 21, 2026. Market Context Zions Bancorporation,…
Read moreRating Change RBC Capital analysts reiterated a Sector Perform rating on Zions Bancorporation, National Association (NASDAQ:ZION) on July 21, 2026. Market Context Zions…
Read moreRating Change Stephens & Co. analysts reiterated a Overweight rating on Zions Bancorporation, National Association (NASDAQ:ZION) on July 21, 2026. Market Context Zions…
Read more
